Part-Time

Clinical Affairs Manager

Updated on 5/26/2026

Aegis Ventures

Aegis Ventures

11-50 employees

Launches AI-driven health tech companies

Compensation Overview

$135 - $175/hr

+ Equity

Remote in USA

Remote

Remote within the U.S.; periodic travel to clinical sites.

Category
Lab & Research (1)
Required Skills
Ruby
biostatistics
Requirements
  • Advanced degree (MSN, MD, or PhD) with 5-10 years of experience
  • Direct experience in obstetrics, neonatal care, or women's health preferred
  • Understanding of fetal monitoring technologies and labor and delivery workflows preferred
  • Experience with clinical research, preferably medical device studies
  • Knowledge of FDA medical device regulations (510k, PMA pathways)
  • Experience with clinical trial design, IRB processes, and Good Clinical Practice compliance
  • Track record of successful regulatory submissions or clinical study management
  • Understanding of biostatistics and clinical data analysis
  • Medical device or healthcare technology background strongly preferred
  • Experience working with hospital systems and clinical decision-makers
  • Understanding of healthcare reimbursement and adoption challenges
  • Familiarity with quality systems and ISO 13485 requirements
Responsibilities
  • Lead clinical study design and execution across multiple hospital sites
  • Manage relationships with clinical investigators and hospital administrators
  • Support FDA regulatory pathway including Q-sub preparation and clinical trial protocols
  • Oversee clinical data collection and analysis for regulatory submissions
  • Establish and maintain relationships with OB/GYN departments and labor and delivery units
  • Guide clinical workflow integration and user experience optimization
  • Support hospital IRB processes and vendor vetting procedures
  • Lead clinical training and education programs for adoption
  • Work closely with engineering team on device usability and clinical requirements
  • Partner with regulatory consultants on FDA strategy and submissions
  • Collaborate with algorithm team on clinical validation of electronic fetal monitoring analysis
  • Interface with business development on hospital partnership negotiations

Aegis Ventures is a startup studio that partners with entrepreneurs and industry leaders to originate, launch, and scale new companies focused on AI and health tech. It operates a platform that combines market-shaping ideas, permanent growth capital, and ambitious people to identify opportunities, fund them long-term, and provide hands-on operational support. Unlike traditional funds, it creates companies in-house with a built-in path to rapid growth, with a strong emphasis on transforming healthcare quality, access, and cost. Its goal is to build companies capable of vast impact by using technology to improve health outcomes and societal wellbeing.

Company Size

11-50

Company Stage

N/A

Total Funding

$33.1M

Headquarters

New York City, New York

Founded

2020

Simplify Jobs

Simplify's Take

What believers are saying

  • John Noseworthy, ex-Mayo CEO, leads Caire virtual care as Executive Chairman.
  • John Driscoll and Cris Ross join as Venture Partners to scale healthtech launches.
  • Ascertain collaboration launches Optain with $12M seed for preventive AI care.

What critics are saying

  • Northwell internalizes Caire, Optain, Upliv, stripping Aegis equity in 6-12 months.
  • Optain's Eyetelligence tech faces FDA rejection due to lacking US validation in 12-18 months.
  • Wavelet's abdominal EEG fails pivotal trials against invasive standards in 18-24 months.

What makes Aegis Ventures unique

  • Aegis launches AI-powered fetal brain monitoring via Wavelet with Yale tech.
  • Aegis partners with Northwell to originate Optain for retinal AI disease detection.
  • Aegis builds healthtech ecosystem across five areas, compressing time-to-market.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Aegis Ventures who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Flexible Work Hours

Company Equity

Wellness Program

Mental Health Support

Company News

Yahoo Finance
Apr 14th, 2026
Yale-born fetal brain monitoring startup Wavelet secures $7M to prevent birth injuries

Wavelet Medical has secured $7 million in seed funding from Aegis Ventures to commercialise the first non-invasive, AI-powered fetal electroencephalography monitoring platform. The technology, developed at Yale, aims to detect fetal brain distress in real time and prevent avoidable brain injury at birth. Founded by Liz Golden, Dr Emily Lee and Dr Jose Cortes-Briones, Wavelet uses EEG captured through the mother's abdomen and reconstructed with AI algorithms to identify neurological distress, addressing limitations of traditional fetal heart rate monitoring, which is indeterminate in up to 85% of births. The platform targets a significant problem: over 35,000 infants suffer birth-related brain injuries annually in the US alone. Wavelet's partnership with Aegis Ventures will accelerate product development, clinical adoption and commercialisation of the technology.

Teknovation.biz
Nov 25th, 2024
News & Notes | Foundersforge Joins Village Capital’S Resource Iii Program For Entrepreneur Support Organizations

From Knoxville: The Knoxville Technology Council is asking local business representatives to complete its latest KTech Pulse 2024 Survey. Noting that the organization wants to get the pulse of Knoxville-area... The post News Notes | FoundersForge joins Village Capitals Resource III Program for Entrepreneur Support Organizations appeared first on Teknovation.biz.

Aegis Ventures
Oct 10th, 2023
Our Focus

We are driven by the mission to build companies that solve society's greatest problems, informed by the belief that the nexus of profits and purpose will create a virtuous cycle of impact that moves the world forward.

PR Newswire
Aug 22nd, 2023
Ascertain Announces Leadership Team With Appointment Of Ceo Mark Michalski, M.D. And Executive Chairman Gregg Fergus

Michalski, an Amazon alum, and Fergus, ex-CEO of 4Catalyzer, will lead the company creation platform building AI applications in healthcare.NEW YORK, Aug. 22, 2023 /PRNewswire/ -- Ascertain, a healthcare AI company creation platform, today announced the formation of its leadership team with the appointment of CEO Mark Michalski, M.D. and Executive Chairman, Gregg Fergus. Michalski and Fergus will lead Ascertain in its mission to merge deep technical, operational, and clinical expertise to deliver high-quality, equitable, and affordable healthcare.Michalski brings two decades of executive leadership experience to Ascertain. Prior to Ascertain, Michalski led strategic development for healthcare and life sciences at Amazon, was Founding Executive Director at Mass General Brigham/Harvard's Center for Clinical Data Science, and served as President and CMO of two publicly traded companies - Butterfly Network and Hyperfine Research. He is a board-certified radiologist and completed his medical training at Yale and Stanford.Fergus and Michalski met and collaborated closely at the venture studio 4Catalyzer where Fergus was CEO, launching several leading healthcare companies including Butterfly Network, Hyperfine Research, AI Therapeutics, and Quantum Si

PR Newswire
Jun 14th, 2023
Aegis Ventures And Northwell Holdings Tap Former Mayo Ceo As Executive Chairman Of Virtual Care Platform, Caire

John Noseworthy takes on key leadership role in next-generation virtual care platform, with health systems at the centerNEW YORK, June 14, 2023 /PRNewswire/ -- Caire, an innovative virtual care ecosystem created by Northwell Holdings and venture studio Aegis Ventures, today announced John Noseworthy, M.D. as Executive Chairman. Noseworthy, the emeritus president and CEO of Mayo Clinic, will lead the Caire Collaborative, a consortium of health systems that serve as investors, early adopters, and clinical partners for Caire's hybrid model of in-person and virtual care. Noseworthy will also serve on Caire's board of directors.Spearheaded by Northwell Health's president and CEO, Michael Dowling, Caire partners with health systems nationwide to redefine how care is delivered. As providers of care and as employers, health systems are uniquely positioned to better identify gaps in care and help build the solutions that address them. Caire, powered by a common operating system for AI-enabled virtual care products, will match patients with the health services they need, when they need it.Caire was founded to address critical issues facing employers today, including providing affordable, accessible, evidenced-based care that can be delivered efficiently, and supporting a patient's longitudinal care journey